Condition: Breast Cancer Screening · Colon Cancer Screening · Genetics Predisposition · Sponsor: Georgetown University
The goal of this study is to test bundled familial cancer risk assessment + multicancer (colorectal + breast) vs. single (breast) cancer navigation, using a wait list control for colorectal cancer screening referral and navigation. Among those eligible, this study will test usual care referral to genetic services vs. pretest education + usual care referral. The study also will assess how bundled multicancer navigation works and for whom it is most effective through a multisite, mixed-methods patient- and organization-level process evaluation.
This description comes directly from the study's public registry record.
Suzanne O'Neill, PhD · 202-687-0869 · sco4@georgetown.edu
Chiranjeev Dash, PhD · 202-687-1542 · cd422@georgetown.edu
Always discuss trial participation with your own doctor first.
| ChristianaCare-Helen F. Graham Cancer Center & Research Institute | Newark, Delaware, United States | Recruiting |
| Georgetown University | Washington D.C., District of Columbia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07228000